Moreover, recent comprehensive transcriptomic analyses using the Cancer Genome Atlas and NanoString PanCancer Immune Profiling datasets have identified ULBP2 expression in tumor tissues as one of the top immune-related gene expressions associated with poor prognosis in both solid tumors and hematologic malignancies [36,37,38,39,40,41,42,43,44]. Here, ULBP2 is linked to neoplasm.